-
Posted by
Two Blokes Jun 13 -
Filed in
Stock
-
30 views
Accelerating the Growth of Globally Active Drug-Discovery Startups from Japan TOKYO , June 13, 2025 /PRNewswire/ -- Mitsubishi Research Institute, Inc. ("MRI") and Astellas Pharma Inc. ("Astellas") today announced that they have agreed on a memorandum of understanding to provide drug-discovery startups in Japan with support in their efforts to go global. The pair aims to strengthen Japan's position as a global hub for drug discovery and foster the growth of its startups that can thrive globally.
